Dermatology Biologics Market, Global Outlook and Forecast 2022-2028

August 2022 | 65 pages | ID: DAD4BCF3F02AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Dermatology Biologics in Global, including the following market information:

Global Dermatology Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dermatology Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Interleukin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dermatology Biologics include Merck and Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Amgen Inc., AstraZenca, Celgene Corporation, Eli Lilly and Company and Johnson and Johnson (Janssen Biotech Inc.). etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatology Biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermatology Biologics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dermatology Biologics Market Segment Percentages, by Type, 2021 (%)

• Interleukin Inhibitors
• Tumor Necrosis Factor Inhibitors

Global Dermatology Biologics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dermatology Biologics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

Global Dermatology Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dermatology Biologics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermatology Biologics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dermatology Biologics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• AbbVie Inc.
• Amgen Inc.
• AstraZenca
• Celgene Corporation
• Eli Lilly and Company
• Johnson and Johnson (Janssen Biotech Inc.)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dermatology Biologics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dermatology Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DERMATOLOGY BIOLOGICS OVERALL MARKET SIZE

2.1 Global Dermatology Biologics Market Size: 2021 VS 2028
2.2 Global Dermatology Biologics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dermatology Biologics Players in Global Market
3.2 Top Global Dermatology Biologics Companies Ranked by Revenue
3.3 Global Dermatology Biologics Revenue by Companies
3.4 Top 3 and Top 5 Dermatology Biologics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermatology Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatology Biologics Players in Global Market
  3.6.1 List of Global Tier 1 Dermatology Biologics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dermatology Biologics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dermatology Biologics Market Size Markets, 2021 & 2028
  4.1.2 Interleukin Inhibitors
  4.1.3 Tumor Necrosis Factor Inhibitors
4.2 By Type - Global Dermatology Biologics Revenue & Forecasts
  4.2.1 By Type - Global Dermatology Biologics Revenue, 2017-2022
  4.2.2 By Type - Global Dermatology Biologics Revenue, 2023-2028
  4.2.3 By Type - Global Dermatology Biologics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dermatology Biologics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 E-Commerce
5.2 By Application - Global Dermatology Biologics Revenue & Forecasts
  5.2.1 By Application - Global Dermatology Biologics Revenue, 2017-2022
  5.2.2 By Application - Global Dermatology Biologics Revenue, 2023-2028
  5.2.3 By Application - Global Dermatology Biologics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dermatology Biologics Market Size, 2021 & 2028
6.2 By Region - Global Dermatology Biologics Revenue & Forecasts
  6.2.1 By Region - Global Dermatology Biologics Revenue, 2017-2022
  6.2.2 By Region - Global Dermatology Biologics Revenue, 2023-2028
  6.2.3 By Region - Global Dermatology Biologics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dermatology Biologics Revenue, 2017-2028
  6.3.2 US Dermatology Biologics Market Size, 2017-2028
  6.3.3 Canada Dermatology Biologics Market Size, 2017-2028
  6.3.4 Mexico Dermatology Biologics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dermatology Biologics Revenue, 2017-2028
  6.4.2 Germany Dermatology Biologics Market Size, 2017-2028
  6.4.3 France Dermatology Biologics Market Size, 2017-2028
  6.4.4 U.K. Dermatology Biologics Market Size, 2017-2028
  6.4.5 Italy Dermatology Biologics Market Size, 2017-2028
  6.4.6 Russia Dermatology Biologics Market Size, 2017-2028
  6.4.7 Nordic Countries Dermatology Biologics Market Size, 2017-2028
  6.4.8 Benelux Dermatology Biologics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dermatology Biologics Revenue, 2017-2028
  6.5.2 China Dermatology Biologics Market Size, 2017-2028
  6.5.3 Japan Dermatology Biologics Market Size, 2017-2028
  6.5.4 South Korea Dermatology Biologics Market Size, 2017-2028
  6.5.5 Southeast Asia Dermatology Biologics Market Size, 2017-2028
  6.5.6 India Dermatology Biologics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dermatology Biologics Revenue, 2017-2028
  6.6.2 Brazil Dermatology Biologics Market Size, 2017-2028
  6.6.3 Argentina Dermatology Biologics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dermatology Biologics Revenue, 2017-2028
  6.7.2 Turkey Dermatology Biologics Market Size, 2017-2028
  6.7.3 Israel Dermatology Biologics Market Size, 2017-2028
  6.7.4 Saudi Arabia Dermatology Biologics Market Size, 2017-2028
  6.7.5 UAE Dermatology Biologics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck and Co. Inc.
  7.1.1 Merck and Co. Inc. Corporate Summary
  7.1.2 Merck and Co. Inc. Business Overview
  7.1.3 Merck and Co. Inc. Dermatology Biologics Major Product Offerings
  7.1.4 Merck and Co. Inc. Dermatology Biologics Revenue in Global Market (2017-2022)
  7.1.5 Merck and Co. Inc. Key News
7.2 Novartis AG
  7.2.1 Novartis AG Corporate Summary
  7.2.2 Novartis AG Business Overview
  7.2.3 Novartis AG Dermatology Biologics Major Product Offerings
  7.2.4 Novartis AG Dermatology Biologics Revenue in Global Market (2017-2022)
  7.2.5 Novartis AG Key News
7.3 Pfizer Inc.
  7.3.1 Pfizer Inc. Corporate Summary
  7.3.2 Pfizer Inc. Business Overview
  7.3.3 Pfizer Inc. Dermatology Biologics Major Product Offerings
  7.3.4 Pfizer Inc. Dermatology Biologics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Inc. Key News
7.4 AbbVie Inc.
  7.4.1 AbbVie Inc. Corporate Summary
  7.4.2 AbbVie Inc. Business Overview
  7.4.3 AbbVie Inc. Dermatology Biologics Major Product Offerings
  7.4.4 AbbVie Inc. Dermatology Biologics Revenue in Global Market (2017-2022)
  7.4.5 AbbVie Inc. Key News
7.5 Amgen Inc.
  7.5.1 Amgen Inc. Corporate Summary
  7.5.2 Amgen Inc. Business Overview
  7.5.3 Amgen Inc. Dermatology Biologics Major Product Offerings
  7.5.4 Amgen Inc. Dermatology Biologics Revenue in Global Market (2017-2022)
  7.5.5 Amgen Inc. Key News
7.6 AstraZenca
  7.6.1 AstraZenca Corporate Summary
  7.6.2 AstraZenca Business Overview
  7.6.3 AstraZenca Dermatology Biologics Major Product Offerings
  7.6.4 AstraZenca Dermatology Biologics Revenue in Global Market (2017-2022)
  7.6.5 AstraZenca Key News
7.7 Celgene Corporation
  7.7.1 Celgene Corporation Corporate Summary
  7.7.2 Celgene Corporation Business Overview
  7.7.3 Celgene Corporation Dermatology Biologics Major Product Offerings
  7.7.4 Celgene Corporation Dermatology Biologics Revenue in Global Market (2017-2022)
  7.7.5 Celgene Corporation Key News
7.8 Eli Lilly and Company
  7.8.1 Eli Lilly and Company Corporate Summary
  7.8.2 Eli Lilly and Company Business Overview
  7.8.3 Eli Lilly and Company Dermatology Biologics Major Product Offerings
  7.8.4 Eli Lilly and Company Dermatology Biologics Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly and Company Key News
7.9 Johnson and Johnson (Janssen Biotech Inc.)
  7.9.1 Johnson and Johnson (Janssen Biotech Inc.) Corporate Summary
  7.9.2 Johnson and Johnson (Janssen Biotech Inc.) Business Overview
  7.9.3 Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Major Product Offerings
  7.9.4 Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Revenue in Global Market (2017-2022)
  7.9.5 Johnson and Johnson (Janssen Biotech Inc.) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dermatology Biologics Market Opportunities & Trends in Global Market
Table 2. Dermatology Biologics Market Drivers in Global Market
Table 3. Dermatology Biologics Market Restraints in Global Market
Table 4. Key Players of Dermatology Biologics in Global Market
Table 5. Top Dermatology Biologics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dermatology Biologics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dermatology Biologics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dermatology Biologics Product Type
Table 9. List of Global Tier 1 Dermatology Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatology Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dermatology Biologics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dermatology Biologics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dermatology Biologics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dermatology Biologics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dermatology Biologics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dermatology Biologics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dermatology Biologics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dermatology Biologics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dermatology Biologics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dermatology Biologics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dermatology Biologics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dermatology Biologics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dermatology Biologics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dermatology Biologics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dermatology Biologics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dermatology Biologics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dermatology Biologics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dermatology Biologics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dermatology Biologics Revenue, (US$, Mn), 2023-2028
Table 30. Merck and Co. Inc. Corporate Summary
Table 31. Merck and Co. Inc. Dermatology Biologics Product Offerings
Table 32. Merck and Co. Inc. Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis AG Corporate Summary
Table 34. Novartis AG Dermatology Biologics Product Offerings
Table 35. Novartis AG Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. Dermatology Biologics Product Offerings
Table 38. Pfizer Inc. Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Inc. Corporate Summary
Table 40. AbbVie Inc. Dermatology Biologics Product Offerings
Table 41. AbbVie Inc. Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Inc. Corporate Summary
Table 43. Amgen Inc. Dermatology Biologics Product Offerings
Table 44. Amgen Inc. Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 45. AstraZenca Corporate Summary
Table 46. AstraZenca Dermatology Biologics Product Offerings
Table 47. AstraZenca Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 48. Celgene Corporation Corporate Summary
Table 49. Celgene Corporation Dermatology Biologics Product Offerings
Table 50. Celgene Corporation Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly and Company Corporate Summary
Table 52. Eli Lilly and Company Dermatology Biologics Product Offerings
Table 53. Eli Lilly and Company Dermatology Biologics Revenue (US$, Mn), (2017-2022)
Table 54. Johnson and Johnson (Janssen Biotech Inc.) Corporate Summary
Table 55. Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Product Offerings
Table 56. Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dermatology Biologics Segment by Type in 2021
Figure 2. Dermatology Biologics Segment by Application in 2021
Figure 3. Global Dermatology Biologics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dermatology Biologics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermatology Biologics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatology Biologics Revenue in 2021
Figure 8. By Type - Global Dermatology Biologics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dermatology Biologics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dermatology Biologics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dermatology Biologics Revenue Market Share, 2017-2028
Figure 12. US Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dermatology Biologics Revenue Market Share, 2017-2028
Figure 16. Germany Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 17. France Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dermatology Biologics Revenue Market Share, 2017-2028
Figure 24. China Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 28. India Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dermatology Biologics Revenue Market Share, 2017-2028
Figure 30. Brazil Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dermatology Biologics Revenue Market Share, 2017-2028
Figure 33. Turkey Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dermatology Biologics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck and Co. Inc. Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis AG Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Inc. Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Inc. Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Inc. Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZenca Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celgene Corporation Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly and Company Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)